ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

0RCQ Nicox Sa

5.67
0.00 (0.00%)
26 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Nicox Sa 0RCQ 런던 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 5.67 09:00:00
개장가 저가 고가 종가 전일 종가
5.67 5.67
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202414:30GLOBENicox : Deuxième convocation à l’Assemblée Générale..
22/04/202414:30GLOBENicox : Point financier sur le premier trimestre 2024 et..
10/04/202400:30GLOBENicox: 2024 Ordinary and Extraordinary Shareholder Meeting
03/04/202400:45GLOBENumber of voting rights as of March 31, 2024
22/03/202415:30GLOBENicox's Shareholder Letter
20/03/202415:30UKREGResults from Mont Blanc Phase 3 Trial of Nicox’s NCX 470 in..
20/03/202415:30UKREGNicox : Publication de résultats de l’étude de phase 3 Mont..
13/03/202415:30UKREGNicox fait le point sur les perspectives de son..
13/03/202415:30UKREGNicox Updates on Corporate, Pipeline and Financing..
05/03/202415:30UKREGNicox Announces Presentation of Data on NCX 470 at the 2024..
05/03/202415:30UKREGNicox : Présentation de données sur le NCX 470 au Congrès..
02/03/202401:45UKREGNombre de droits de vote au 29 février 2024
02/03/202401:45UKREGNumber of voting rights as of February 29, 2024
28/02/202415:30UKREGNicox Appoints Experienced Biotech Executive Gavin Spencer..
28/02/202415:30UKREGNicox Restructures Debt, Streamlines Operations to Extend..
28/02/202415:30UKREGGavin Spencer, dirigeant expérimenté du secteur de la..
28/02/202415:30UKREGNicox restructure sa dette et réduit sa structure pour ..
08/02/202415:30UKREGNicox and Kowa Enter into Agreement for NCX 470 Development..
08/02/202415:30UKREGNicox : Contrat de licence avec la société Kowa pour le..
06/02/202415:30UKREGNicox : Présentations au prochain Congrès Annuel 2024 de..
06/02/202415:30UKREGNicox announces presentations at the upcoming Association..
02/02/202401:45UKREGNombre de droits de vote au 31 janvier 2024
02/02/202401:45UKREGNumber of votings rights as of January 31 2024
31/01/202415:30UKREGNicox : Prolongation de 5 ans de la durée d’un brevet..
31/01/202415:30UKREGNicox Receives Confirmation of 5-year Patent Term Extension..
25/01/202415:30UKREGNicox : Résumé financier et point d’activité du quatrième..
25/01/202415:30UKREGNicox Provides Fourth Quarter 2023 Financial and Business..
08/01/202415:30GLOBENicox : Half-year liquidity contract statement with Kepler..
03/01/202415:30GLOBENicox : Termination of the liquidity contract with Kepler..
03/01/202401:45GLOBENumber of voting rights as of December 31, 2023
18/12/202315:30GLOBENicox : Pré-sélection du premier patient dans l’étude de..
14/12/202315:30GLOBENicox’s Announces Publication of New Nonclinical Data..
02/12/202301:45GLOBENumber of voting rights as of November 30, 2023
03/11/202301:45GLOBENombre de droits de vote au 31 octobre 2023
20/10/202314:30GLOBENicox : Résultats financiers du premier semestre 2023 et du..
20/10/202314:00GLOBENicox : Rapport semestriel financier et d’activité 2023
03/10/202300:30GLOBEPUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE..
02/10/202314:30GLOBENicox confirme son éligibilité au PEA-PME
02/09/202300:45GLOBEPUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE..
02/08/202300:45GLOBEPUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE..
19/07/202314:30GLOBENicox Provides Second Quarter 2023 Financial and Business..
11/07/202314:30GLOBENicox: Half-year liquidity contract statement with Kepler..
10/07/202314:30GLOBENicox Estimates Potential Annual Global Net Sales for NCX..
04/07/202300:45GLOBEMONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE..
03/07/202314:30GLOBENicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design..
02/06/202314:30GLOBENicox: 2023 Ordinary Shareholder Meeting
02/06/202301:30GLOBEPUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE..
04/05/202300:45GLOBENumber of voting rights as of April 30, 2023

최근 히스토리

Delayed Upgrade Clock